No Data Available
CARE Ratings Share Price
| Open | 1,630.00 |
| High | 1,661.70 |
| Low | 1,615.10 |
| Prev Close | 1,625.00 |
| Volume | 32,054 |
| VWAP(₹) | 1,642.66 |
Key Metrics
| PE Ratio(x) | 28.59 |
| EPS - TTM(₹) | 56.97 |
| MCap(₹ Cr.) | 4,894.66 |
| MCap Rank | 35 |
| PB Ratio(x) | 5.18 |
| Div Yield(%) | 1.35 |
| Face Value(₹) | 10.00 |
| 52W High(₹) | 1,964.00 |
| 52W Low(₹) | 1,392.70 |
| MCap/Sales | 9.15 |
| Beta(1 Month) | 2.28 |
| BV/Share(₹) | 313.88 |
CARE Ratings share price insights
Dividend Announcement
Company announced a dividend of Rs 14.0 per share on May 13, 2026 with record date of Jun 26, 2026.Zero Debt Burden
Company has no debt since last 5 years. (Source: Consolidated Financials)Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 45.38% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)CARE Ratings Share Price Update
CARE Ratings Ltd. share price moved up by 0.25% from its previous close of Rs 1,625.00. CARE Ratings Ltd. stock last traded price is 1,629.00
Share Price Value Today/Current/Last 1,629.00 Previous Day 1,625.00
Found Insights useful?
CARE Ratings Share Price Returns
| 1 Day | 0.25% |
| 1 Month | -1.29% |
| 3 Months | 0.62% |
| 1 Year | -11.41% |
| 3 Years | 139.17% |
| 5 Years | 183.5% |
CARE Ratings Share Recommendations
- Target₹748
- OrganizationHDFC Securities
- BUY
- Target₹760
- OrganizationICICI Direct
- BUY
- Target₹550
- OrganizationIIFL
- BUY
News & Analysis
Financials
Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Total Income 146.38 125.11 148.95 107.60 124.82 Total Income Growth (%) 16.99 -16.00 38.42 -13.80 15.33 Total Expenses 73.74 75.47 71.42 69.56 65.34 Total Expenses Growth (%) -2.29 5.67 2.67 6.46 -5.23 EBIT 72.63 49.64 77.53 38.04 59.48 EBIT Growth (%) 46.32 -35.97 103.80 -36.05 51.43 Profit after Tax (PAT) 52.83 35.90 56.67 25.78 42.61 PAT Growth (%) 47.19 -36.66 119.83 -39.50 53.25 EBIT Margin (%) 49.62 39.68 52.05 35.35 47.65 Net Profit Margin (%) 36.09 28.69 38.05 23.96 34.14 Basic EPS (₹) 17.58 11.96 18.90 8.61 14.24 All figures in Rs Cr, unless mentioned otherwise
InsightsEmployee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 45.38% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
Annual FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 Total Assets 1,104.74 957.74 841.76 771.03 727.41 Total Assets Growth (%) 15.35 13.78 9.17 6.00 8.28 Total Liabilities 161.61 142.24 117.17 91.99 74.60 Total Liabilities Growth (%) 13.62 21.39 27.38 23.31 -5.25 Total Equity 943.13 815.50 724.58 679.04 652.81 Total Equity Growth (%) 15.65 12.55 6.71 4.02 10.08 Current Ratio (x) 5.76 7.08 8.57 10.19 11.01 Total Debt to Equity (x) 0.00 0.00 0.00 0.00 0.00 Contingent Liabilities 0.00 11.86 7.96 8.77 3.66 All figures in Rs Cr, unless mentioned otherwise
InsightsZero Debt Burden
Company has no debt since last 5 years. (Source: Consolidated Financials)
Annual FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 Net Cash flow from Operating Activities 147.68 122.95 90.88 82.24 68.00 Net Cash used in Investing Activities -94.56 -58.43 -39.07 12.88 -27.32 Net Cash flow from Financing Activities -59.33 -54.00 -62.96 -63.33 -35.14 Net Cash Flow -6.22 10.53 -11.14 31.79 5.55 Closing Cash & Cash Equivalent 42.60 48.82 38.29 49.42 17.63 Closing Cash & Cash Equivalent Growth (%) -12.73 27.50 -22.54 180.30 49.61 Total Debt/ CFO (x) 0.00 0.00 0.00 0.00 0.00 All figures in Rs Cr, unless mentioned otherwise
InsightsIncrease in Cash from Investing
Company has used Rs 94.45 cr for investing activities which is an YoY increase of 61.66%. (Source: Consolidated Financials)
Annual FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 Return on Equity (%) 18.35 17.02 14.01 12.42 11.59 Return on Capital Employed (%) 24.09 22.60 19.43 17.80 14.65 Return on Assets (%) 15.49 14.32 11.94 10.83 10.32 Interest Coverage Ratio (x) 101.45 97.76 92.77 137.04 230.27 Asset Turnover Ratio (x) 0.46 0.45 0.41 0.33 0.32 Price to Earnings (x) 25.32 24.04 33.22 22.88 20.24 Price to Book (x) 4.64 4.09 4.65 2.84 2.34 EV/EBITDA (x) 16.68 15.56 20.68 13.55 13.50 EBITDA Margin (%) 53.31 51.22 47.88 49.20 43.12 InsightsBuilding-up Cash Reserves
Company has consistently increased ROE in last 5 years with majority of profits being added to its reserves last year. (Source: Consolidated Financials)
Found Financials useful?
Technicals
- 41%Positive Movement
since 1st Jan 2005
on basis59%Negative Movement
since 1st Jan 2005
on basisExcludeGlobal Meltdown1st Jan 2008 to 10th Nov 2008
Covid Crisis1st Feb 2020 to 31st Mar 2020
R1 - Pivot -
S1 - R2 - S2 - R3 - S3 - 5 Days 14 Days 28 Days - - -
Peer Comparison
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Choose from Peers
Choose from Stocks
Mutual Funds Ownership
No Data Available
CARE Ratings Top Searches
Corporate Actions
Board Meeting
Quarterly Results
Feb 02, 2026
General Meeting
-
Dec 16, 2025
Interim Dividend
80%
Nov 12, 2025
Announced on Meeting on Feb 02, 2026 Feb 11, 2026 Quarterly Results Nov 04, 2025 Nov 12, 2025 Quarterly Results & Interim Dividend Jul 23, 2025 Aug 05, 2025 Quarterly Results May 02, 2025 May 12, 2025 Audited Results & Final Dividend Jan 20, 2025 Jan 30, 2025 Quarterly Results Announced on Ex-Date Dividend% Nov 12, 2025 Nov 19, 2025 80% May 12, 2025 Jun 27, 2025 110% Oct 23, 2024 Nov 05, 2024 70% May 10, 2024 Jun 21, 2024 110% Oct 31, 2023 Nov 10, 2023 70% No Data Available
No Data Available
No Data Available
Announced on Meeting on Dec 16, 2025 Jan 19, 2026 - Sep 16, 2025 Oct 20, 2025 - Jun 18, 2025 Jul 10, 2025 - May 10, 2024 Jul 09, 2024 - May 12, 2023 Jul 28, 2023 -
About CARE Ratings
CARE Ratings Ltd., incorporated in the year 1993, is a Small Cap company (having a market cap of Rs 4,894.66 Crore) operating in Financial Services sector.
Industry
Key Indices Listed On
BSE SmallCap, BSE Financial Services, BSE AllCap, BSE Next 250 Microcap, BSE NEXT 500
Address
4th Floor, Godrej Coliseum,Somaiya Hospital Road,Off Eastern Express Highway,Mumbai, Maharashtra - 400022
Executive Leadership
V Chandrasekaran
Chairman & Ind.Dire (Non-Exe)Mehul Harshadray Pandya
Managing Director & Group CEOAnanda Prakash Jha
CEO - CARE Ratings Nepal Ltd.Saurav Chatterjee
Director & CEOAuditors
FAQs about CARE Ratings share
- 1. What's CARE Ratings share price today and what are CARE Ratings share returns ?As on 10 Jun, 2026, 03:56 PM IST CARE Ratings share price is up by 0.25% basis the previous closing price of Rs 1,597.4. CARE Ratings share price is Rs 1,629.00. Return Performance of CARE Ratings Shares:
- 1 Week: CARE Ratings share price moved up by 0.39%
- 2. What's the market capitalization of CARE Ratings ?Market Capitalization of CARE Ratings stock is Rs 4,894.66 Cr.
- 3. What has been highest price of CARE Ratings share in last 52 weeks?52 Week high of CARE Ratings share is Rs 1,964.00 while 52 week low is Rs 1,392.70
- 4. What is the PE & PB ratio of CARE Ratings ?The PE ratio of CARE Ratings stands at 28.52, while the PB ratio is 5.18.
- 5. What are the returns for CARE Ratings share?Return Performance of CARE Ratings Shares:
- 1 Week: CARE Ratings share price moved up by 0.39%
Top Gainers
As on 03:59 PM | 10 Jun 2026Top Losers
As on 03:59 PM | 10 Jun 2026Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.